Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elagolix Alone or With Add-Back for Endometriosis Pain
NCT03343067Phase 3Terminated
- Sponsor
- AbbVie Inc.
- Start
- Dec 2017
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of elagolix in endometriosis, sponsored by AbbVie Inc.. Started Dec 2017; status: terminated.
02
Drugs
elagolix
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT03343067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03343067.